ALPINE IMMUNE SCIENCES, INC. Pre-Tax Income
ALPINE IMMUNE SCIENCES, INC. reported Pre-Tax Income of -$32.08 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2024-03-20
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2023-12-31 was $6.06M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2023-09-30 was -$11.72M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2023-06-30 was -$13.16M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2023-03-31 was -$13.27M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$32.08M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$55.43M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$50.42M.
- ALPINE IMMUNE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$27.95M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$5.66M derived: sum of 2 quarters · filed 2024-03-20 | -$18.82M derived: sum of 3 quarters · filed 2024-03-20 | -$32.08M 10-K · filed 2024-03-20 |
| 2023-09-30 | -$11.72M 10-Q · filed 2023-11-14 | -$24.88M derived: sum of 2 quarters · filed 2023-11-14 | -$38.14M 10-Q · filed 2023-11-14 | -$56.46M derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-06-30 | -$13.16M 10-Q · filed 2023-08-14 | -$26.42M 10-Q · filed 2023-08-14 | -$44.74M derived: sum of 3 quarters · filed 2024-03-20 | -$58.01M derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-03-31 | -$13.27M 10-Q · filed 2023-05-11 | -$31.58M derived: sum of 2 quarters · filed 2024-03-20 | -$44.85M derived: sum of 3 quarters · filed 2024-03-20 | -$61.17M derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$31.59M derived: sum of 2 quarters · filed 2024-03-20 | -$47.91M derived: sum of 3 quarters · filed 2024-03-20 | -$55.43M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$13.27M 10-Q · filed 2023-11-14 | -$29.59M derived: sum of 2 quarters · filed 2023-11-14 | -$37.12M 10-Q · filed 2023-11-14 | -$52.58M derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-06-30 | -$16.32M 10-Q · filed 2023-08-14 | -$23.84M 10-Q · filed 2023-08-14 | -$39.31M derived: sum of 3 quarters · filed 2024-03-20 | -$52.72M derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-03-31 | -$7.52M 10-Q · filed 2023-05-11 | -$22.99M derived: sum of 2 quarters · filed 2024-03-20 | -$36.40M derived: sum of 3 quarters · filed 2024-03-20 | -$47.30M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-12-31 | -$15.46M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$28.88M derived: sum of 2 quarters · filed 2024-03-20 | -$39.78M derived: sum of 3 quarters · filed 2024-03-20 | -$50.42M 10-K · filed 2024-03-20 |
| 2021-09-30 | -$13.41M 10-Q · filed 2022-11-14 | -$24.31M derived: sum of 2 quarters · filed 2022-11-14 | -$34.95M 10-Q · filed 2022-11-14 | -$41.30M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | -$10.90M 10-Q · filed 2022-08-11 | -$21.54M 10-Q · filed 2022-08-11 | -$27.88M derived: sum of 3 quarters · filed 2023-03-23 | -$34.02M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | -$10.64M 10-Q · filed 2022-05-12 | -$16.98M derived: sum of 2 quarters · filed 2023-03-23 | -$23.12M derived: sum of 3 quarters · filed 2023-03-23 | -$33.06M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | -$6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$12.48M derived: sum of 2 quarters · filed 2023-03-23 | -$22.41M derived: sum of 3 quarters · filed 2023-03-23 | -$27.95M 10-K · filed 2023-03-23 |
| 2020-09-30 | -$6.14M 10-Q · filed 2021-11-10 | -$16.07M derived: sum of 2 quarters · filed 2021-11-10 | -$21.60M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$9.93M 10-Q · filed 2021-08-10 | -$15.47M 10-Q · filed 2021-08-10 | ||
| 2019-12-31 | -$6.14M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$17.61M derived: sum of 2 quarters · filed 2022-03-17 | -$29.47M derived: sum of 3 quarters · filed 2022-03-17 | -$41.85M 10-K · filed 2022-03-17 |
| 2019-09-30 | -$11.47M 10-Q · filed 2020-11-12 | -$23.33M derived: sum of 2 quarters · filed 2020-11-12 | -$35.71M 10-Q · filed 2020-11-12 | -$46.91M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | -$11.86M 10-Q · filed 2020-08-11 | -$24.24M 10-Q · filed 2020-08-11 | -$35.43M derived: sum of 3 quarters · filed 2021-03-18 | -$47.57M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | -$12.38M 10-Q · filed 2019-05-09 | -$23.58M derived: sum of 2 quarters · filed 2021-03-18 | -$35.72M derived: sum of 3 quarters · filed 2021-03-18 | -$43.88M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | -$11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$23.34M derived: sum of 2 quarters · filed 2021-03-18 | -$31.50M derived: sum of 3 quarters · filed 2021-03-18 | -$36.85M 10-K · filed 2021-03-18 |
| 2018-09-30 | -$12.14M 10-Q · filed 2019-11-14 | -$20.30M derived: sum of 2 quarters · filed 2019-11-14 | -$25.66M 10-Q · filed 2019-11-14 | -$30.18M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-06-30 | -$8.16M 10-Q · filed 2019-08-13 | -$13.52M 10-Q · filed 2019-08-13 | -$18.04M derived: sum of 3 quarters · filed 2020-03-30 | -$15.91M derived: sum of 4 quarters · filed 2020-03-30 |
| 2018-03-31 | -$5.36M 10-Q · filed 2019-05-09 | -$9.88M derived: sum of 2 quarters · filed 2020-03-30 | -$7.75M derived: sum of 3 quarters · filed 2020-03-30 | -$11.35M derived: sum of 4 quarters · filed 2020-03-30 |
| 2017-12-31 | -$4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$2.40M derived: sum of 2 quarters · filed 2020-03-30 | -$5.99M derived: sum of 3 quarters · filed 2020-03-30 | -$7.98M 10-K · filed 2020-03-30 |
| 2017-09-30 | $2.13M 10-Q · filed 2018-11-08 | -$1.47M derived: sum of 2 quarters · filed 2018-11-08 | -$3.46M 10-Q · filed 2018-11-08 | -$4.44M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | -$3.60M 10-Q · filed 2018-08-09 | -$5.59M 10-Q · filed 2018-08-09 | -$6.57M derived: sum of 3 quarters · filed 2019-03-18 | -$6.94M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | -$1.99M 10-Q · filed 2018-05-14 | -$2.97M derived: sum of 2 quarters · filed 2019-03-18 | -$3.34M derived: sum of 3 quarters · filed 2019-03-18 | |
| 2016-12-31 | -$981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.35M derived: sum of 2 quarters · filed 2019-03-18 | -$1.17M 10-K · filed 2019-03-18 | |
| 2016-09-30 | -$374.00K 10-Q · filed 2017-11-14 | -$185.00K 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | -$369.00K 10-K · filed 2018-03-28 |